La maladie de Parkinson au Canada (serveur d'exploration)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Glucocorticoid Excess Induces Accumulation of Cardiac Glycogen and Triglyceride: Suggested Role for AMPK : Metabolic Syndrome and Cardiovascular Health: A Look Beyond the Horizon

Identifieur interne : 000079 ( PascalFrancis/Corpus ); précédent : 000078; suivant : 000080

Glucocorticoid Excess Induces Accumulation of Cardiac Glycogen and Triglyceride: Suggested Role for AMPK : Metabolic Syndrome and Cardiovascular Health: A Look Beyond the Horizon

Auteurs : Prasanth Puthanveetil ; Brian Rodrigues

Source :

RBID : Pascal:13-0258530

Descripteurs français

English descriptors

Abstract

Glucocorticoids include steroid hormones released from the adrenal cortex or synthetic analogues developed for various inflammatory and immune disorders. GCs are known to play an important role in maintaining the body's metabolic balance, but their irregular activity has been associated with complications like Cushing's syndrome, insulin resistance, and heart disease. Conventional GC action is through their nuclear receptor activation, but specific and non-specific membrane bound receptor mediated non-genomic actions have also been reported. GCs increase AMPK phosphorylation at Thr172, in addition to augmenting AMPK protein and gene expressions. AMPK is insulin mimetic in many of its actions like glucose uptake and inhibition of lipolysis, and these properties of AMPK are made used in conditions like insulin resistance and diabetes. Nevertheless, if AMPK is activated by GC in the absence of diabetes or decreased insulin signaling, accumulation of substrates in the form of glycogen and triglycerides could precipitate cardiac abnormalities. Glycogen storage can lead to many disorders like hypertrophy, conduction system disease and Wolff Parkinson White syndrome. TG accumulation is associated with generation of free radicals, ceramide formation, mitochondrial dysfunction and cardiac cell death. In this review, we outline the cardiometabolic changes associated with GC, especially related to augmentation in AMPK, and link these changes to cardiac dysfunction.

Notice en format standard (ISO 2709)

Pour connaître la documentation sur le format Inist Standard.

pA  
A01 01  1    @0 1381-6128
A03   1    @0 Curr. pharm. des. : (Print)
A05       @2 19
A06       @2 27
A08 01  1  ENG  @1 Glucocorticoid Excess Induces Accumulation of Cardiac Glycogen and Triglyceride: Suggested Role for AMPK : Metabolic Syndrome and Cardiovascular Health: A Look Beyond the Horizon
A11 01  1    @1 PUTHANVEETIL (Prasanth)
A11 02  1    @1 RODRIGUES (Brian)
A14 01      @1 Faculty of Pharmaceutical Sciences, The University of British Columbia, 2146 East Mall @2 Vancouver, BC V6T 1Z3 @3 CAN @Z 1 aut. @Z 2 aut.
A20       @1 4818-4830
A21       @1 2013
A23 01      @0 ENG
A43 01      @1 INIST @2 26320 @5 354000506523700030
A44       @0 0000 @1 © 2013 INIST-CNRS. All rights reserved.
A45       @0 205 ref.
A47 01  1    @0 13-0258530
A60       @1 P
A61       @0 A
A64 01  1    @0 Current pharmaceutical design : (Print)
A66 01      @0 ARE
C01 01    ENG  @0 Glucocorticoids include steroid hormones released from the adrenal cortex or synthetic analogues developed for various inflammatory and immune disorders. GCs are known to play an important role in maintaining the body's metabolic balance, but their irregular activity has been associated with complications like Cushing's syndrome, insulin resistance, and heart disease. Conventional GC action is through their nuclear receptor activation, but specific and non-specific membrane bound receptor mediated non-genomic actions have also been reported. GCs increase AMPK phosphorylation at Thr172, in addition to augmenting AMPK protein and gene expressions. AMPK is insulin mimetic in many of its actions like glucose uptake and inhibition of lipolysis, and these properties of AMPK are made used in conditions like insulin resistance and diabetes. Nevertheless, if AMPK is activated by GC in the absence of diabetes or decreased insulin signaling, accumulation of substrates in the form of glycogen and triglycerides could precipitate cardiac abnormalities. Glycogen storage can lead to many disorders like hypertrophy, conduction system disease and Wolff Parkinson White syndrome. TG accumulation is associated with generation of free radicals, ceramide formation, mitochondrial dysfunction and cardiac cell death. In this review, we outline the cardiometabolic changes associated with GC, especially related to augmentation in AMPK, and link these changes to cardiac dysfunction.
C02 01  X    @0 002B12A01
C03 01  X  FRE  @0 Glucocorticoïde @5 01
C03 01  X  ENG  @0 Glucocorticoid @5 01
C03 01  X  SPA  @0 Glucocorticoide @5 01
C03 02  X  FRE  @0 Accumulation biologique @5 02
C03 02  X  ENG  @0 Biological accumulation @5 02
C03 02  X  SPA  @0 Acumulación biológica @5 02
C03 03  X  FRE  @0 Coeur @5 03
C03 03  X  ENG  @0 Heart @5 03
C03 03  X  SPA  @0 Corazón @5 03
C03 04  X  FRE  @0 Glycogène @5 04
C03 04  X  ENG  @0 Glycogen @5 04
C03 04  X  SPA  @0 Glicógeno @5 04
C03 05  X  FRE  @0 Triglycéride @5 05
C03 05  X  ENG  @0 Triglyceride @5 05
C03 05  X  SPA  @0 Triglicérido @5 05
C03 06  X  FRE  @0 cAMP-dependent protein kinase @2 FE @5 06
C03 06  X  ENG  @0 cAMP-dependent protein kinase @2 FE @5 06
C03 06  X  SPA  @0 cAMP-dependent protein kinase @2 FE @5 06
C03 07  X  FRE  @0 Métabolisme @5 07
C03 07  X  ENG  @0 Metabolism @5 07
C03 07  X  SPA  @0 Metabolismo @5 07
C03 08  X  FRE  @0 Insuffisance cardiaque @5 08
C03 08  X  ENG  @0 Heart failure @5 08
C03 08  X  SPA  @0 Insuficiencia cardíaca @5 08
C03 09  X  FRE  @0 Article synthèse @5 09
C03 09  X  ENG  @0 Review @5 09
C03 09  X  SPA  @0 Artículo síntesis @5 09
C07 01  X  FRE  @0 Lipide @5 38
C07 01  X  ENG  @0 Lipids @5 38
C07 01  X  SPA  @0 Lípido @5 38
C07 02  X  FRE  @0 Pathologie de l'appareil circulatoire @5 40
C07 02  X  ENG  @0 Cardiovascular disease @5 40
C07 02  X  SPA  @0 Aparato circulatorio patología @5 40
C07 03  X  FRE  @0 Cardiopathie @5 41
C07 03  X  ENG  @0 Heart disease @5 41
C07 03  X  SPA  @0 Cardiopatía @5 41
N21       @1 245

Format Inist (serveur)

NO : PASCAL 13-0258530 INIST
ET : Glucocorticoid Excess Induces Accumulation of Cardiac Glycogen and Triglyceride: Suggested Role for AMPK : Metabolic Syndrome and Cardiovascular Health: A Look Beyond the Horizon
AU : PUTHANVEETIL (Prasanth); RODRIGUES (Brian)
AF : Faculty of Pharmaceutical Sciences, The University of British Columbia, 2146 East Mall/Vancouver, BC V6T 1Z3/Canada (1 aut., 2 aut.)
DT : Publication en série; Niveau analytique
SO : Current pharmaceutical design : (Print); ISSN 1381-6128; Emirats Arabes Unis; Da. 2013; Vol. 19; No. 27; Pp. 4818-4830; Bibl. 205 ref.
LA : Anglais
EA : Glucocorticoids include steroid hormones released from the adrenal cortex or synthetic analogues developed for various inflammatory and immune disorders. GCs are known to play an important role in maintaining the body's metabolic balance, but their irregular activity has been associated with complications like Cushing's syndrome, insulin resistance, and heart disease. Conventional GC action is through their nuclear receptor activation, but specific and non-specific membrane bound receptor mediated non-genomic actions have also been reported. GCs increase AMPK phosphorylation at Thr172, in addition to augmenting AMPK protein and gene expressions. AMPK is insulin mimetic in many of its actions like glucose uptake and inhibition of lipolysis, and these properties of AMPK are made used in conditions like insulin resistance and diabetes. Nevertheless, if AMPK is activated by GC in the absence of diabetes or decreased insulin signaling, accumulation of substrates in the form of glycogen and triglycerides could precipitate cardiac abnormalities. Glycogen storage can lead to many disorders like hypertrophy, conduction system disease and Wolff Parkinson White syndrome. TG accumulation is associated with generation of free radicals, ceramide formation, mitochondrial dysfunction and cardiac cell death. In this review, we outline the cardiometabolic changes associated with GC, especially related to augmentation in AMPK, and link these changes to cardiac dysfunction.
CC : 002B12A01
FD : Glucocorticoïde; Accumulation biologique; Coeur; Glycogène; Triglycéride; cAMP-dependent protein kinase; Métabolisme; Insuffisance cardiaque; Article synthèse
FG : Lipide; Pathologie de l'appareil circulatoire; Cardiopathie
ED : Glucocorticoid; Biological accumulation; Heart; Glycogen; Triglyceride; cAMP-dependent protein kinase; Metabolism; Heart failure; Review
EG : Lipids; Cardiovascular disease; Heart disease
SD : Glucocorticoide; Acumulación biológica; Corazón; Glicógeno; Triglicérido; cAMP-dependent protein kinase; Metabolismo; Insuficiencia cardíaca; Artículo síntesis
LO : INIST-26320.354000506523700030
ID : 13-0258530

Links to Exploration step

Pascal:13-0258530

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en" level="a">Glucocorticoid Excess Induces Accumulation of Cardiac Glycogen and Triglyceride: Suggested Role for AMPK : Metabolic Syndrome and Cardiovascular Health: A Look Beyond the Horizon</title>
<author>
<name sortKey="Puthanveetil, Prasanth" sort="Puthanveetil, Prasanth" uniqKey="Puthanveetil P" first="Prasanth" last="Puthanveetil">Prasanth Puthanveetil</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Faculty of Pharmaceutical Sciences, The University of British Columbia, 2146 East Mall</s1>
<s2>Vancouver, BC V6T 1Z3</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Rodrigues, Brian" sort="Rodrigues, Brian" uniqKey="Rodrigues B" first="Brian" last="Rodrigues">Brian Rodrigues</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Faculty of Pharmaceutical Sciences, The University of British Columbia, 2146 East Mall</s1>
<s2>Vancouver, BC V6T 1Z3</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">INIST</idno>
<idno type="inist">13-0258530</idno>
<date when="2013">2013</date>
<idno type="stanalyst">PASCAL 13-0258530 INIST</idno>
<idno type="RBID">Pascal:13-0258530</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000079</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en" level="a">Glucocorticoid Excess Induces Accumulation of Cardiac Glycogen and Triglyceride: Suggested Role for AMPK : Metabolic Syndrome and Cardiovascular Health: A Look Beyond the Horizon</title>
<author>
<name sortKey="Puthanveetil, Prasanth" sort="Puthanveetil, Prasanth" uniqKey="Puthanveetil P" first="Prasanth" last="Puthanveetil">Prasanth Puthanveetil</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Faculty of Pharmaceutical Sciences, The University of British Columbia, 2146 East Mall</s1>
<s2>Vancouver, BC V6T 1Z3</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Rodrigues, Brian" sort="Rodrigues, Brian" uniqKey="Rodrigues B" first="Brian" last="Rodrigues">Brian Rodrigues</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Faculty of Pharmaceutical Sciences, The University of British Columbia, 2146 East Mall</s1>
<s2>Vancouver, BC V6T 1Z3</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</analytic>
<series>
<title level="j" type="main">Current pharmaceutical design : (Print)</title>
<title level="j" type="abbreviated">Curr. pharm. des. : (Print)</title>
<idno type="ISSN">1381-6128</idno>
<imprint>
<date when="2013">2013</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<title level="j" type="main">Current pharmaceutical design : (Print)</title>
<title level="j" type="abbreviated">Curr. pharm. des. : (Print)</title>
<idno type="ISSN">1381-6128</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Biological accumulation</term>
<term>Glucocorticoid</term>
<term>Glycogen</term>
<term>Heart</term>
<term>Heart failure</term>
<term>Metabolism</term>
<term>Review</term>
<term>Triglyceride</term>
<term>cAMP-dependent protein kinase</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr">
<term>Glucocorticoïde</term>
<term>Accumulation biologique</term>
<term>Coeur</term>
<term>Glycogène</term>
<term>Triglycéride</term>
<term>cAMP-dependent protein kinase</term>
<term>Métabolisme</term>
<term>Insuffisance cardiaque</term>
<term>Article synthèse</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Glucocorticoids include steroid hormones released from the adrenal cortex or synthetic analogues developed for various inflammatory and immune disorders. GCs are known to play an important role in maintaining the body's metabolic balance, but their irregular activity has been associated with complications like Cushing's syndrome, insulin resistance, and heart disease. Conventional GC action is through their nuclear receptor activation, but specific and non-specific membrane bound receptor mediated non-genomic actions have also been reported. GCs increase AMPK phosphorylation at Thr172, in addition to augmenting AMPK protein and gene expressions. AMPK is insulin mimetic in many of its actions like glucose uptake and inhibition of lipolysis, and these properties of AMPK are made used in conditions like insulin resistance and diabetes. Nevertheless, if AMPK is activated by GC in the absence of diabetes or decreased insulin signaling, accumulation of substrates in the form of glycogen and triglycerides could precipitate cardiac abnormalities. Glycogen storage can lead to many disorders like hypertrophy, conduction system disease and Wolff Parkinson White syndrome. TG accumulation is associated with generation of free radicals, ceramide formation, mitochondrial dysfunction and cardiac cell death. In this review, we outline the cardiometabolic changes associated with GC, especially related to augmentation in AMPK, and link these changes to cardiac dysfunction.</div>
</front>
</TEI>
<inist>
<standard h6="B">
<pA>
<fA01 i1="01" i2="1">
<s0>1381-6128</s0>
</fA01>
<fA03 i2="1">
<s0>Curr. pharm. des. : (Print)</s0>
</fA03>
<fA05>
<s2>19</s2>
</fA05>
<fA06>
<s2>27</s2>
</fA06>
<fA08 i1="01" i2="1" l="ENG">
<s1>Glucocorticoid Excess Induces Accumulation of Cardiac Glycogen and Triglyceride: Suggested Role for AMPK : Metabolic Syndrome and Cardiovascular Health: A Look Beyond the Horizon</s1>
</fA08>
<fA11 i1="01" i2="1">
<s1>PUTHANVEETIL (Prasanth)</s1>
</fA11>
<fA11 i1="02" i2="1">
<s1>RODRIGUES (Brian)</s1>
</fA11>
<fA14 i1="01">
<s1>Faculty of Pharmaceutical Sciences, The University of British Columbia, 2146 East Mall</s1>
<s2>Vancouver, BC V6T 1Z3</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
</fA14>
<fA20>
<s1>4818-4830</s1>
</fA20>
<fA21>
<s1>2013</s1>
</fA21>
<fA23 i1="01">
<s0>ENG</s0>
</fA23>
<fA43 i1="01">
<s1>INIST</s1>
<s2>26320</s2>
<s5>354000506523700030</s5>
</fA43>
<fA44>
<s0>0000</s0>
<s1>© 2013 INIST-CNRS. All rights reserved.</s1>
</fA44>
<fA45>
<s0>205 ref.</s0>
</fA45>
<fA47 i1="01" i2="1">
<s0>13-0258530</s0>
</fA47>
<fA60>
<s1>P</s1>
</fA60>
<fA61>
<s0>A</s0>
</fA61>
<fA64 i1="01" i2="1">
<s0>Current pharmaceutical design : (Print)</s0>
</fA64>
<fA66 i1="01">
<s0>ARE</s0>
</fA66>
<fC01 i1="01" l="ENG">
<s0>Glucocorticoids include steroid hormones released from the adrenal cortex or synthetic analogues developed for various inflammatory and immune disorders. GCs are known to play an important role in maintaining the body's metabolic balance, but their irregular activity has been associated with complications like Cushing's syndrome, insulin resistance, and heart disease. Conventional GC action is through their nuclear receptor activation, but specific and non-specific membrane bound receptor mediated non-genomic actions have also been reported. GCs increase AMPK phosphorylation at Thr172, in addition to augmenting AMPK protein and gene expressions. AMPK is insulin mimetic in many of its actions like glucose uptake and inhibition of lipolysis, and these properties of AMPK are made used in conditions like insulin resistance and diabetes. Nevertheless, if AMPK is activated by GC in the absence of diabetes or decreased insulin signaling, accumulation of substrates in the form of glycogen and triglycerides could precipitate cardiac abnormalities. Glycogen storage can lead to many disorders like hypertrophy, conduction system disease and Wolff Parkinson White syndrome. TG accumulation is associated with generation of free radicals, ceramide formation, mitochondrial dysfunction and cardiac cell death. In this review, we outline the cardiometabolic changes associated with GC, especially related to augmentation in AMPK, and link these changes to cardiac dysfunction.</s0>
</fC01>
<fC02 i1="01" i2="X">
<s0>002B12A01</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE">
<s0>Glucocorticoïde</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG">
<s0>Glucocorticoid</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA">
<s0>Glucocorticoide</s0>
<s5>01</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE">
<s0>Accumulation biologique</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG">
<s0>Biological accumulation</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA">
<s0>Acumulación biológica</s0>
<s5>02</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE">
<s0>Coeur</s0>
<s5>03</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG">
<s0>Heart</s0>
<s5>03</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA">
<s0>Corazón</s0>
<s5>03</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE">
<s0>Glycogène</s0>
<s5>04</s5>
</fC03>
<fC03 i1="04" i2="X" l="ENG">
<s0>Glycogen</s0>
<s5>04</s5>
</fC03>
<fC03 i1="04" i2="X" l="SPA">
<s0>Glicógeno</s0>
<s5>04</s5>
</fC03>
<fC03 i1="05" i2="X" l="FRE">
<s0>Triglycéride</s0>
<s5>05</s5>
</fC03>
<fC03 i1="05" i2="X" l="ENG">
<s0>Triglyceride</s0>
<s5>05</s5>
</fC03>
<fC03 i1="05" i2="X" l="SPA">
<s0>Triglicérido</s0>
<s5>05</s5>
</fC03>
<fC03 i1="06" i2="X" l="FRE">
<s0>cAMP-dependent protein kinase</s0>
<s2>FE</s2>
<s5>06</s5>
</fC03>
<fC03 i1="06" i2="X" l="ENG">
<s0>cAMP-dependent protein kinase</s0>
<s2>FE</s2>
<s5>06</s5>
</fC03>
<fC03 i1="06" i2="X" l="SPA">
<s0>cAMP-dependent protein kinase</s0>
<s2>FE</s2>
<s5>06</s5>
</fC03>
<fC03 i1="07" i2="X" l="FRE">
<s0>Métabolisme</s0>
<s5>07</s5>
</fC03>
<fC03 i1="07" i2="X" l="ENG">
<s0>Metabolism</s0>
<s5>07</s5>
</fC03>
<fC03 i1="07" i2="X" l="SPA">
<s0>Metabolismo</s0>
<s5>07</s5>
</fC03>
<fC03 i1="08" i2="X" l="FRE">
<s0>Insuffisance cardiaque</s0>
<s5>08</s5>
</fC03>
<fC03 i1="08" i2="X" l="ENG">
<s0>Heart failure</s0>
<s5>08</s5>
</fC03>
<fC03 i1="08" i2="X" l="SPA">
<s0>Insuficiencia cardíaca</s0>
<s5>08</s5>
</fC03>
<fC03 i1="09" i2="X" l="FRE">
<s0>Article synthèse</s0>
<s5>09</s5>
</fC03>
<fC03 i1="09" i2="X" l="ENG">
<s0>Review</s0>
<s5>09</s5>
</fC03>
<fC03 i1="09" i2="X" l="SPA">
<s0>Artículo síntesis</s0>
<s5>09</s5>
</fC03>
<fC07 i1="01" i2="X" l="FRE">
<s0>Lipide</s0>
<s5>38</s5>
</fC07>
<fC07 i1="01" i2="X" l="ENG">
<s0>Lipids</s0>
<s5>38</s5>
</fC07>
<fC07 i1="01" i2="X" l="SPA">
<s0>Lípido</s0>
<s5>38</s5>
</fC07>
<fC07 i1="02" i2="X" l="FRE">
<s0>Pathologie de l'appareil circulatoire</s0>
<s5>40</s5>
</fC07>
<fC07 i1="02" i2="X" l="ENG">
<s0>Cardiovascular disease</s0>
<s5>40</s5>
</fC07>
<fC07 i1="02" i2="X" l="SPA">
<s0>Aparato circulatorio patología</s0>
<s5>40</s5>
</fC07>
<fC07 i1="03" i2="X" l="FRE">
<s0>Cardiopathie</s0>
<s5>41</s5>
</fC07>
<fC07 i1="03" i2="X" l="ENG">
<s0>Heart disease</s0>
<s5>41</s5>
</fC07>
<fC07 i1="03" i2="X" l="SPA">
<s0>Cardiopatía</s0>
<s5>41</s5>
</fC07>
<fN21>
<s1>245</s1>
</fN21>
</pA>
</standard>
<server>
<NO>PASCAL 13-0258530 INIST</NO>
<ET>Glucocorticoid Excess Induces Accumulation of Cardiac Glycogen and Triglyceride: Suggested Role for AMPK : Metabolic Syndrome and Cardiovascular Health: A Look Beyond the Horizon</ET>
<AU>PUTHANVEETIL (Prasanth); RODRIGUES (Brian)</AU>
<AF>Faculty of Pharmaceutical Sciences, The University of British Columbia, 2146 East Mall/Vancouver, BC V6T 1Z3/Canada (1 aut., 2 aut.)</AF>
<DT>Publication en série; Niveau analytique</DT>
<SO>Current pharmaceutical design : (Print); ISSN 1381-6128; Emirats Arabes Unis; Da. 2013; Vol. 19; No. 27; Pp. 4818-4830; Bibl. 205 ref.</SO>
<LA>Anglais</LA>
<EA>Glucocorticoids include steroid hormones released from the adrenal cortex or synthetic analogues developed for various inflammatory and immune disorders. GCs are known to play an important role in maintaining the body's metabolic balance, but their irregular activity has been associated with complications like Cushing's syndrome, insulin resistance, and heart disease. Conventional GC action is through their nuclear receptor activation, but specific and non-specific membrane bound receptor mediated non-genomic actions have also been reported. GCs increase AMPK phosphorylation at Thr172, in addition to augmenting AMPK protein and gene expressions. AMPK is insulin mimetic in many of its actions like glucose uptake and inhibition of lipolysis, and these properties of AMPK are made used in conditions like insulin resistance and diabetes. Nevertheless, if AMPK is activated by GC in the absence of diabetes or decreased insulin signaling, accumulation of substrates in the form of glycogen and triglycerides could precipitate cardiac abnormalities. Glycogen storage can lead to many disorders like hypertrophy, conduction system disease and Wolff Parkinson White syndrome. TG accumulation is associated with generation of free radicals, ceramide formation, mitochondrial dysfunction and cardiac cell death. In this review, we outline the cardiometabolic changes associated with GC, especially related to augmentation in AMPK, and link these changes to cardiac dysfunction.</EA>
<CC>002B12A01</CC>
<FD>Glucocorticoïde; Accumulation biologique; Coeur; Glycogène; Triglycéride; cAMP-dependent protein kinase; Métabolisme; Insuffisance cardiaque; Article synthèse</FD>
<FG>Lipide; Pathologie de l'appareil circulatoire; Cardiopathie</FG>
<ED>Glucocorticoid; Biological accumulation; Heart; Glycogen; Triglyceride; cAMP-dependent protein kinase; Metabolism; Heart failure; Review</ED>
<EG>Lipids; Cardiovascular disease; Heart disease</EG>
<SD>Glucocorticoide; Acumulación biológica; Corazón; Glicógeno; Triglicérido; cAMP-dependent protein kinase; Metabolismo; Insuficiencia cardíaca; Artículo síntesis</SD>
<LO>INIST-26320.354000506523700030</LO>
<ID>13-0258530</ID>
</server>
</inist>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/PascalFrancis/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000079 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Corpus/biblio.hfd -nk 000079 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    PascalFrancis
   |étape=   Corpus
   |type=    RBID
   |clé=     Pascal:13-0258530
   |texte=   Glucocorticoid Excess Induces Accumulation of Cardiac Glycogen and Triglyceride: Suggested Role for AMPK : Metabolic Syndrome and Cardiovascular Health: A Look Beyond the Horizon
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022